The pharmaceutical and biotech industries use microwave technology for drug discovery and quality control. CEM offers a wide array of systems to help companies in their pursuit of new drug candidates and therapies, as well as ensuring quality control and conformation to Good Manufacturing Practices (GMP) and governmental regulations.
Research Highlights
Microwave Peptide Synthesis
by Grace Vanier, PhD
Drug Discovery & Development
August 1, 2011
Cambridge Research Biochemicals Expands Peptide Synthesis Capacity with Liberty System
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids
Martin M. Fabani, et al.
Nucleic Acids Research Advance Access published online on March 11, 2010
Microwave Peptide Synthesis
by Grace Vanier, PhD
Drug Discovery & Development
August 1, 2011
Cambridge Research Biochemicals Expands Peptide Synthesis Capacity with Liberty System
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids
Martin M. Fabani, et al.
Nucleic Acids Research Advance Access published online on March 11, 2010
USP Method 231 & Proposed Methods 232, 233, & 2232
USP Methods for sample preparation and analysis of elements of interest will be changing in 2012. CEM can help prepare your laboratory with instrumentation, training, and applications assistance. Find out more in our on-demand webinar.
Click here to browse through a few of the many applications that are available on our site.
USP Methods for sample preparation and analysis of elements of interest will be changing in 2012. CEM can help prepare your laboratory with instrumentation, training, and applications assistance. Find out more in our on-demand webinar.
Click here to browse through a few of the many applications that are available on our site.
